Investor Relations

Upcoming Events

BTIG Virtual Biotechnology Conference 2021

H.C. Wainwright 23rd Annual Global Investment Conference

Lake Street BIG5 Conference

Company Overview

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company developing recombinant proteins to improve the lives of patients who experience a stroke or recurrent strokes and kidney diseases.

Investor Contact Information


DiaMedica Therapeutics, Inc.
Two Carlson Parkway,
Suite 260
Minneapolis, MN 55447

Investor Relations

LifeSci Advisors, LLC
Timothy McCarthy, CFA
Managing Director, Relationship Manager
T: 212.915.2564

DiaMedica Therapeutics Inc.
Scott Kellen
Chief Financial Officer
T: (763) 496-5192
F: (763) 710-4456